Inducing tolerance in primates
AssigneeTolerRx, Inc.
InventorsDawn Winsor-Hines, Patricia Rao, Douglas J. Ringler
Life of this patent
Estimating the term…
Abstract
The present invention is based, at least in part, on the finding that tolerance can be induced by inhibition of CD4+ and CD8+ T cells. Accordingly, the methods of the invention are useful in treating a primate, e.g., a human, by inhibiting CD4+ and CD8+ T cells to induce tolerance to at least one antigen, e.g., self or foreign, such as for inducting tolerance in a primate against a transplanted antigen, e.g., an allogeneic or xenogeneic transplanted antigen.
Claims3
A process for treating a primate to induce tolerance to at least one antigen comprising:
- administering to the primate at least one anti-CD4 antibody or CD4 binding fragment thereof and at least one compound that inhibits CD8+ T cells each in an amount and for a time effective to induce tolerance against at least one antigen, said anti-CD4 antibody or fragment being present in said primate when said antigen is present in said primate and said anti-CD4 antibody being administered in an initial dose of at least 40 mg/kg, such that tolerance against said antigen is induced.
A process for inducing tolerance in a primate to a transplanted antigen, comprising:
- administering to a primate at least one anti-CD4 antibody or CD4 binding fragment thereof and at least one compound that inhibits CD8+ T cells each in an amount and for a time effective to induce tolerance against the transplant, said anti-CD4 antibody or fragment being present in said primate when said transplanted antigen is present in said primate and said anti-CD4 antibody being administered in an initial dose of at least 40 mg/kg, such that tolerance to the transplanted antigen is induced.
Dependencies are inferred from the claim text.